Literature DB >> 475409

Plasma 17OH-progesterone concentrations in newborn infants.

I A Hughes, D Riad-Fahmy, K Griffiths.   

Abstract

Plasma concentrations of 17OH-progesterone were determined in 60 normal newborn infants aged between 3 and 36 hours. Mean levels decreased rapidly during this time after removal of the placental contribution of this steroid. A further 70 normal infants, studied between ages 2 and 7 days, showed a mean plasma 17OH-progesterone concentration of 3.5 nmol/1 (1.2 ng/ml). By comparison, plasma concentrations in untreated infants with congenital adrenal hyperplasia were markedly raised. At 36 hours of age, there was an obvious difference between plasma levels of this steroid in normal and affected infants. Determination of plasma 17OH-progesterone concentrations are valuable in the evaluation of disorders of sexual differentiation and electrolyte balance in newborn infants, provided due care is given to the timing of sample collections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475409      PMCID: PMC1545574          DOI: 10.1136/adc.54.5.347

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone.

Authors:  E Youssefnejadian; R David
Journal:  Clin Endocrinol (Oxf)       Date:  1975-07       Impact factor: 3.478

2.  Early diagnosis of salt-losing congenital adrenal hyperplasia in a newborn boy.

Authors:  I A Hughes; J S Winter
Journal:  Can Med Assoc J       Date:  1977-08-20       Impact factor: 8.262

3.  Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.

Authors:  N D Barnes; S M Atherden
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

4.  Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.

Authors:  B M Lippe; S H LaFranchi; N Lavin; A Parlow; J Coyotupa; S A Kaplan
Journal:  J Pediatr       Date:  1974-12       Impact factor: 4.406

5.  Sources of plasma 17alpha-hydroxyprogesterone in human pregnancy.

Authors:  D Tulchinsky; H H Simmer
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

6.  Internal quality control of radioimmunoassays.

Authors:  K W Kemp; A B Nix; D W Wilson; K Griffiths
Journal:  J Endocrinol       Date:  1978-02       Impact factor: 4.286

7.  Ontogenic study of plasma 17alpha-hydroxyprogesterone in the human. I. Postnatal period: evidence for a transient ovarian activity in infancy.

Authors:  M G Forest; A M Cathiard
Journal:  Pediatr Res       Date:  1978-01       Impact factor: 3.756

8.  Pituitary-gonadal relations in infancy: 2. Patterns of serum gonadal steroid concentrations in man from birth to two years of age.

Authors:  J S Winter; I A Hughes; F I Reyes; C Faiman
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

9.  The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.

Authors:  I A Hughes; J S Winter
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

10.  Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery.

Authors:  W G Sippell; H Becker; H T Versmold; F Bidlingmaier; D Knorr
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

  10 in total
  11 in total

1.  Effect of gender, birth weight and gestational age on serum 17-hydroxyprogesterone concentration and distribution among neonates in Saudi Arabia.

Authors:  A R al-Nuaim; M A Abdullah; B Stevens; M Zain
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.

Authors:  Eric Giannoni; Laurence Guignard; Marlies Knaup Reymond; Matthieu Perreau; Matthias Roth-Kleiner; Thierry Calandra; Thierry Roger
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.

Authors:  I A Hughes
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

4.  Unusual dual genital duct remnants in true hermaphroditism.

Authors:  C Williams; I A Hughes
Journal:  J Med Genet       Date:  1988-03       Impact factor: 6.318

Review 5.  Management of congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

6.  Measurement of urine 17-oxogenic steroids, 17-hydroxycorticosteroids, and 17-oxosteroids has been superseded by better tests.

Authors:  B T Rudd
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

7.  Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.

Authors:  J F Murphy; B G Joyce; J Dyas; I A Hughes
Journal:  Arch Dis Child       Date:  1983-07       Impact factor: 3.791

8.  Value of selective screening for congenital adrenal hyperplasia in Hungary.

Authors:  J Sólyom; I A Hughes
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

9.  Prenatal diagnosis of congenital adrenal hyperplasia: reliability of amniotic fluid steroid analysis.

Authors:  I A Hughes; J Dyas; D Riad-Fahmy; K M Laurence
Journal:  J Med Genet       Date:  1987-06       Impact factor: 6.318

10.  Should we screen for congenital adrenal hyperplasia? A review of 117 cases.

Authors:  N K Virdi; P H Rayner; B T Rudd; A Green
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.